- Offers Advanced Educational Resources and Training for Veteran Recruits
- New Web Portal Address: www.mvpvets.org
CARLSBAD, Calif., Feb. 5, 2014 (GLOBE NEWSWIRE) -- The Medical Technology Veterans Program, renamed the MedTech and BioTech Veterans Program (MVP), has expanded nationwide and to industries across the life sciences. MVP is a career-training and mentorship program, designed to help veterans transition into jobs in the medical technology (medtech), biotechnology (biotech), life sciences and diagnostic industries. This successful program has expanded nationwide to offer customized educational programs aimed at preparing veterans for impactful and meaningful employment as professionals in the life sciences. As part of this expansion, the new MVP web portal will now be located at www.mvpvets.org .Foundational partners of MVP, including heart pump manufacturer, Abiomed, Inc., and medical device trade association AdvaMed, will also welcome a new partner, BioCollaborative, to assist in reaching additional veterans from around the country and providing cutting edge industry-focused training. With its expertise in developing and administering customized eLearning platforms, BioCollaborative is an ideal partner to assist in equipping job-seeking veterans with pragmatic learning solutions necessary to succeed in the job market. "This expansion and new partnership will enable us to reach more veterans and mentors from all over the country and provide quality training and mentorship for our service men and women who are looking to build a career in the life sciences and medical technology industries," said Michael Minogue, Chief Executive Officer of Abiomed and MVP Chairman. "I am also excited to introduce MVP's new President, Mike Grice, a veteran with a 27-year career in the United States Marine Corps. and a former professor at National University, a great fit for the program."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts